+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort



Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort



Scandinavian Journal of Gastroenterology 53(9): 1027-1030



Use of antibiotics affects the composition of the gut microbiome. The microbiome is thought to play a role in development of irritable bowel syndrome (IBS), but antibiotics as a possible risk factor for IBS has not been clarified. We aimed to explore if antibiotics is a risk factor for IBS by investigating use of antibiotics and development of IBS in a cohort from the Danish background population. An internet-based web panel representative of the Danish background population was invited to participate in a survey regarding the epidemiology of IBS in 2010, 2011 and 2013. A questionnaire based on the Rome III criteria for IBS were answered at all three occasions. In 2013, a question regarding use of antibiotics in the past year was included. In 2013, use of antibiotics was reported by 22.4% (624/2781) of the population. A higher proportion of individuals with IBS reported use of antibiotics compared with asymptomatic controls [29.0% (155/534) vs. 17.9% (212/1,184), p < .01]. For asymptomatic respondents in 2010 and 2011 (n = 1004), the relative risk of IBS in 2013 related with use of antibiotics was 1.9 [95% confidence interval (CI): 1.1-3.1]. Adjusting for sex by logistic regression, development of IBS was predicted by use of antibiotics with an odds ratio of 1.8 (95% CI: 1.0-3.2). Antibiotics is a risk factor for IBS in asymptomatic individuals. Possible mechanisms should be investigated in future studies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065693797

Download citation: RISBibTeXText

PMID: 30189148

DOI: 10.1080/00365521.2018.1500638


Related references

A nationwide population cohort study: irritable bowel syndrome is a risk factor of osteoporosis. European Journal of Internal Medicine 25(1): 87-91, 2014

Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study. Plos One 10(7): E0133283, 2016

Risk of psychiatric disorders in irritable bowel syndrome-A nationwide, population-based, cohort study. International Journal of Clinical Practice 72(7): E13212, 2018

Biliary events and an increased risk of new onset irritable bowel syndrome a population-based cohort study. Alimentary Pharmacology and Therapeutics 28(3): 334-343, 2008

The risk of irritable bowel syndrome in patients with endometriosis during a 5-year follow-up: a nationwide population-based cohort study. International Journal of Colorectal Disease 30(7): 907-912, 2016

Risk of fractures at different anatomic sites in patients with irritable bowel syndrome: a nationwide population-based cohort study. Archives of Osteoporosis 13(1): 80, 2018

Increased subsequent risk of erectile dysfunction in patients with irritable bowel syndrome: a nationwide population-based cohort study. Andrology 1(5): 793-798, 2014

So-eum type as an independent risk factor for irritable bowel syndrome: a population-based study in Korea. Journal of Alternative and Complementary Medicine 20(11): 846-852, 2015

Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. European Journal of Gastroenterology and Hepatology 18(10): 1101-1109, 2006

Association between migraine and irritable bowel syndrome: a population-based retrospective cohort study. European Journal of Neurology 21(9): 1198-1204, 2015

Bidirectional Association between Asthma and Irritable Bowel Syndrome: Two Population-Based Retrospective Cohort Studies. Plos One 11(4): E0153911, 2016

Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study. World Journal of Gastroenterology 23(19): 3513-3521, 2018

A 8-year population-based cohort study of irritable bowel syndrome in childhood with history of atopic dermatitis. Journal of Investigative Medicine 66(4): 755-761, 2018

Irritable Bowel Syndrome Increases the Risk of Epilepsy: A Population-Based Study. Medicine 94(36): E1497, 2015

The epidemiology of irritable bowel syndrome: Symptom development over a 3-year period in Denmark. A prospective, population-based cohort study. Neurogastroenterology and Motility 29(4), 2016